Search results for "thiazole"
showing 10 items of 244 documents
CCDC 957337: Experimental Crystal Structure Determination
2014
Related Article: L. Koskinen, S. Jaaskelainen, E. Kalenius, P. Hirva and M. Haukka|2014|Cryst.Growth Des.|14|1989|doi:10.1021/cg500102c
CCDC 1900284: Experimental Crystal Structure Determination
2019
Related Article: Sirpa Jääskeläinen, Laura Koskinen, Matti Haukka, Pipsa Hirva|2019|Solid State Sciences|97|105980|doi:10.1016/j.solidstatesciences.2019.105980
CCDC 241490: Experimental Crystal Structure Determination
2006
Related Article: M.Gonzalez-Alvarez, G.Alzuet, J.Borras, L.del C.Agudo, S.Garcia-Granda, J.M.Montejo-Bernando|2005|Inorg.Chem.|44|9424|doi:10.1021/ic050110c
CCDC 194206: Experimental Crystal Structure Determination
2003
Related Article: M.Gonzalez-Alvarez, G.Alzuet, J.Borras, B.Macias, J.M.Montejo-Bernardo, S.Garcia-Granda|2003|Z.Anorg.Allg.Chem.|629|239|doi:10.1002/zaac.200390038
CCDC 1420813: Experimental Crystal Structure Determination
2018
Related Article: Inese Sarceviča, IlzeGrante, Sergey Belyakov, Toms Rekis, Kārlis Bērziņš, Andris Actiņš, Liāna Orola|2016|J.Pharm.Sci.|105|1489|doi:10.1016/j.xphs.2016.01.024
CCDC 2209231: Experimental Crystal Structure Determination
2022
Related Article: Miguel Gavara-Edo, Francisco Javier Valverde-Muñoz, Rosa Córdoba, M. Carmen Muñoz, Javier Herrero-Martín, José Antonio Real, Eugenio Coronado|2022|J.Mater.Chem.C|11|8107|doi:10.1039/D2TC04120K
CCDC 2209227: Experimental Crystal Structure Determination
2022
Related Article: Miguel Gavara-Edo, Francisco Javier Valverde-Muñoz, Rosa Córdoba, M. Carmen Muñoz, Javier Herrero-Martín, José Antonio Real, Eugenio Coronado|2022|J.Mater.Chem.C|11|8107|doi:10.1039/D2TC04120K
CCDC 1982286: Experimental Crystal Structure Determination
2020
Related Article: Eugene A. Katlenok, Matti Haukka, Oleg V. Levin, Antonio Frontera, Vadim Yu. Kukushkin|2020|Chem.-Eur.J.|26|7692|doi:10.1002/chem.202001196
Discovery and structure-activity relationship studies of irreversible benzisothiazolinone-based inhibitors against Staphylococcus aureus sortase A tr…
2014
Gram-positive bacteria, in general, and staphylococci, in particular, are the widespread cause of nosocomial and community-acquired infections. The rapid evolvement of strains resistant to antibiotics currently in use is a serious challenge. Novel antimicrobial compounds have to be developed to fight these resistant bacteria, and sortase A, a bacterial cell wall enzyme, is a promising target for novel therapies. As a transpeptidase that covalently attaches various virulence factors to the cell surface, this enzyme plays a crucial role in the ability of bacteria to invade the host's tissues and to escape the immune response. In this study we have screened a small molecule library against rec…
In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils
2009
Aims: To evaluate the anti-biofilm activity of the commercially available essential oils from two Boswellia species. Methods and Results: The susceptibility of staphylococcal and Candida albicans biofilms was determined by methyltiazotetrazolium (MTT) staining. At concentrations ranging from 217·3 μg ml−1 (25% v/v) to 6·8 μg ml−1 (0·75% v/v), the essential oil of Boswellia papyrifera showed considerable activity against both Staphylococcus epidermidis DSM 3269 and Staphylococcus aureus ATCC 29213 biofilms. The anti-microbial efficacy of this oil against S. epidermidis RP62A biofilms was also tested using live/dead staining in combination with fluorescence microscopy, and we observed that …